CoQ10 has not been linked to harmful effects in pregnant women in the clinical trials conducted so far, and the available evidence suggests it is generally well tolerated at typical supplement doses. That said, no major health organization has issued a formal recommendation either for or against taking it during pregnancy, largely because the safety data comes from a handful of relatively small studies rather than large-scale trials designed specifically to test for adverse effects. The question gets more interesting when you look at what CoQ10 actually does during pregnancy and the conditions it may help prevent.
Your Body Already Ramps Up CoQ10 During Pregnancy
CoQ10 is not a foreign substance you’re introducing to your body for the first time when you take a supplement. It’s a compound your cells already make, and pregnancy triggers a notable increase in production. Plasma CoQ10 levels rise steadily from the first trimester through the third, tracking alongside increases in cholesterol and other lipids that fuel fetal development.1PubMed. Positive correlation between maternal serum coenzyme Q10 levels and infant birth weight This upward trend appears to be part of normal pregnancy physiology, helping the body keep pace with the sharply higher energy demands of growing a placenta and fetus.
What happens when that natural rise falls short? Researchers have observed that women with lower-than-expected CoQ10 levels face a higher likelihood of spontaneous abortion.2Fetal Diagnosis and Therapy. Coenzyme Q10 in Pregnancy This doesn’t prove that low CoQ10 causes miscarriage; the relationship could easily reflect a broader problem, like poor placental development, that simultaneously drags CoQ10 levels down and raises miscarriage risk. But it does suggest that adequate CoQ10 levels are at least a marker of a healthy pregnancy, and potentially a contributor to one.
The Preeclampsia Evidence
The strongest clinical evidence for CoQ10 supplementation during pregnancy comes from research on preeclampsia, a dangerous condition involving high blood pressure and organ damage that develops after the 20th week. In a randomized, placebo-controlled trial of women at elevated risk, those who received CoQ10 starting at 20 weeks had roughly half the rate of preeclampsia compared to the placebo group: about 14% versus 26%.3PubMed. Coenzyme Q10 supplementation during pregnancy reduces the risk of pre-eclampsia That’s a meaningful reduction, and the study found no safety concerns with supplementation at the dose used (200 mg per day).
Animal research has added some texture to this finding. In a rat model of preeclampsia, CoQ10 improved mitochondrial function in the placenta, restoring energy production that the condition had compromised.4PubMed. CoQ10 alleviate preeclampsia symptoms by enhancing the function of mitochondria in the placenta of pregnant rats with preeclampsia A separate rat study found that CoQ10 lowered blood pressure in preeclamptic animals by influencing key proteins involved in blood vessel formation.5PubMed. Implication of nuclear factor-erythroid 2-like 2/heme oxygenase 1 pathway in the protective effects of coenzyme Q10 against preeclampsia-like in a rat model
There’s an important caveat, though. One study examining placentas from women with preeclampsia who had taken CoQ10 found that while overall placental CoQ10 content went up, the levels inside the mitochondria themselves didn’t budge.6Free Radical Biology and Medicine. Placental and mitochondrial Q10 content after CoQ10 supplementation during pregnancy In other words, the supplement reached the placental tissue but didn’t seem to penetrate the exact cellular compartment where preeclampsia does much of its damage. This disconnect may help explain why CoQ10 reduced preeclampsia rates without eliminating them entirely, and it suggests the mechanism of benefit might be more about systemic antioxidant protection than direct mitochondrial repair in the placenta.
Before Pregnancy and Egg Quality
A substantial body of interest in CoQ10 actually begins before conception. For women undergoing IVF, egg quality is a central concern, and mitochondrial energy production in the egg is one of the factors that determines whether a fertilized embryo develops normally. A study of women going through IVF found that those who took CoQ10 before their treatment cycle had a lower rate of chromosomally abnormal eggs compared to a control group: roughly 47% versus 63%.7Clinical Medicine Insights: Reproductive Health. Coenzyme Q10 Supplementation and Oocyte Aneuploidy in Women Undergoing IVF-ICSI Treatment Clinical pregnancy rates also trended higher in the CoQ10 group, though the study was small.
Researchers have proposed that CoQ10’s benefit to egg quality stems from its role in mitochondrial energy production. As eggs age, their mitochondria become less efficient, and CoQ10 is a key part of the chain that generates the cellular energy eggs need to divide properly. This has led some fertility specialists to suggest CoQ10 supplementation for women over 35 or those with diminished ovarian reserve, though this remains an area of active investigation rather than established medical consensus.8PubMed Central. Coenzyme Q10 Stimulate Reproductive Vatality
What About Gestational Diabetes
The relationship between CoQ10 and gestational diabetes is less straightforward than the preeclampsia story. Rather than showing that supplementation helps, the primary finding in this area is that women with gestational diabetes tend to have elevated CoQ10 levels relative to cholesterol in late pregnancy, alongside markers of increased oxidative stress and insulin resistance.9PubMed. Plasma coenzyme Q10 is increased during gestational diabetes
This is where the nuance matters. Higher circulating CoQ10 in gestational diabetes likely reflects the body’s attempt to counteract oxidative damage, not a cause of the problem. It’s a compensatory response, similar to how your body produces more white blood cells during an infection. The elevated CoQ10 is a sign of the stress, not the stressor itself. No clinical trial has yet established whether supplementing with CoQ10 improves outcomes for women with gestational diabetes, so if you’ve been diagnosed with GDM, CoQ10 is not a known treatment.
Safety Profile and Side Effects
The clinical trial that tested CoQ10 for preeclampsia prevention used a dose of 200 mg per day from week 20 of pregnancy onward and reported no significant adverse effects in either mothers or infants.3PubMed. Coenzyme Q10 supplementation during pregnancy reduces the risk of pre-eclampsia Outside of pregnancy, CoQ10 has been studied extensively for cardiovascular conditions, and its side-effect profile is mild. The most commonly reported issues are stomach upset, nausea, and diarrhea, and these tend to be dose-related.
Preclinical work has added a somewhat unusual but reassuring data point. In a chick embryo model, researchers found that co-administering CoQ10 alongside certain antidepressants actually reduced the teratogenic effects those drugs caused, lowering both malformation and mortality rates in the embryos.10PubMed. Protective effects of CoQ10 and L-carnitine against antidepressant-induced mitochondrial dysfunction and teratogenicity in chicken embryos This is an animal model and doesn’t directly translate to human pregnancies, but it suggests CoQ10 is protective against developmental harm rather than a source of it.
Still, the honest assessment is that no study has enrolled thousands of pregnant women and followed them specifically to catalog every possible side effect of CoQ10 supplementation. What we have instead are smaller trials focused on specific outcomes like preeclampsia, where side effects were tracked as a secondary measure and nothing concerning turned up. That absence of detected harm is reassuring but not the same thing as a clean bill of health from a dedicated safety trial. Your obstetrician should know about any supplement you’re taking, because CoQ10 can interact with blood thinners and blood-pressure medications.
Ubiquinol Versus Ubiquinone
If you’ve started shopping for CoQ10 supplements, you’ve probably noticed two forms on the shelf: ubiquinone and ubiquinol. Ubiquinone is the oxidized form and was the original supplement formulation. Ubiquinol is the reduced (active) form that your body actually uses. Your cells naturally convert ubiquinone to ubiquinol after you absorb it, so both forms ultimately work, but they’re absorbed differently.
Research comparing the two has found that ubiquinol is absorbed more efficiently from the gut. In one trial, 200 mg per day of ubiquinol was roughly 70% more bioavailable than the same dose of ubiquinone, and daily doses of up to 300 mg were well tolerated over a four-week period.11PubMed Central. Ubiquinol in Fertility and Reproduction: A Conditionally Essential Nutrient for Critical Early-Life Stages For a pregnant woman, this means you could potentially take a lower dose of ubiquinol and achieve similar blood levels, which may reduce the chance of gastrointestinal side effects. Ubiquinol supplements tend to cost more, though, so the practical trade-off is price versus absorption efficiency.
Most of the pregnancy-specific clinical trials used ubiquinone, because that was the form widely available when the research was conducted. If you’re choosing ubiquinol based on the bioavailability data, keep in mind that the pregnancy safety evidence is primarily built on ubiquinone at 200 mg per day. The two forms are biochemically interconvertible in the body, so there’s no strong theoretical reason to think ubiquinol would behave differently, but it hasn’t been tested as extensively in pregnant populations.
Doses Used in Pregnancy Research
The studies that have tested CoQ10 supplementation during pregnancy have mostly clustered around 200 mg per day. The preeclampsia trial used that dose beginning at 20 weeks of gestation.3PubMed. Coenzyme Q10 supplementation during pregnancy reduces the risk of pre-eclampsia Fertility studies have used similar or slightly lower doses in the weeks or months before conception. There’s no established upper limit for pregnancy specifically, but the general adult literature suggests doses up to 1,200 mg per day are tolerated in non-pregnant people for conditions like Parkinson’s disease and heart failure.
That doesn’t mean higher doses are better or advisable during pregnancy. The principle of using the lowest effective dose is especially relevant here, where large-scale dose-ranging studies in pregnant women simply haven’t been done. If your practitioner recommends CoQ10, expect a dose in the 100 to 200 mg range, which is consistent with the existing trial evidence.
The Gap Between Evidence and Guidelines
If CoQ10 cut preeclampsia rates in half and shows no safety red flags, why isn’t every obstetrician recommending it? The honest reason is that the evidence, while promising, rests on a thin base. The key preeclampsia trial enrolled just over 230 women. Replications in larger, more diverse populations haven’t been completed yet. Medical guidelines typically require stronger evidence before adding a new supplement to routine prenatal care, and for good reason: the history of prenatal supplementation includes plenty of substances that looked beneficial in early trials but failed to hold up, or even caused harm, at scale.
There’s also the practical question of who would fund a large confirmatory trial. CoQ10 is a generic, widely available supplement with no patent protection, which means no pharmaceutical company stands to profit from proving it works. This funding gap is a real barrier in supplement research and helps explain why the evidence has stalled at the promising-but-preliminary stage for over a decade.
For now, CoQ10 sits in a category shared by several other supplements: likely safe, possibly beneficial for specific conditions, but not yet part of standard prenatal protocols. If you’re at elevated risk for preeclampsia and interested in trying it, that conversation belongs with your obstetrician, who can weigh it against your full medical picture.
CoQ10 in Breast Milk After Delivery
The question of CoQ10 safety extends past delivery for women who plan to breastfeed. Interestingly, CoQ10 is naturally present in breast milk, and colostrum (the earliest milk produced in the first days after birth) is a particularly rich source. CoQ10 concentrations in milk decline gradually over the first weeks of lactation, following a pattern that suggests early, concentrated delivery to the newborn is biologically intentional.12PubMed. Coenzyme Q10 in maternal plasma and milk throughout early lactation
In early milk, there’s a correlation between a mother’s plasma CoQ10 levels and the amount that shows up in breast milk. That correlation fades as milk matures, suggesting that the early transfer is more tightly regulated than the later supply. Whether maternal supplementation with CoQ10 meaningfully changes the amount a nursing infant receives hasn’t been studied directly. Given that the newborn’s own CoQ10 production ramps up quickly after birth, this may be a short window where maternal levels matter most.
No safety concerns have been raised about CoQ10 in the context of breastfeeding, but the same caveat applies as in pregnancy: the absence of reported problems in small studies is not the same as a formal safety clearance. If you were taking CoQ10 during pregnancy and plan to continue while nursing, mention it to your pediatrician as well.
Who Should Be Most Cautious
A few groups of pregnant women should approach CoQ10 supplementation with extra care. If you’re taking blood-thinning medication like warfarin, CoQ10 can reduce the drug’s effectiveness because of its structural similarity to vitamin K. Women on blood-pressure medications should also be aware that CoQ10 has mild blood-pressure-lowering effects of its own, which could potentially amplify the medication’s action. Neither interaction is dangerous if monitored, but your prescriber needs to know.
Women with a history of blood clots or clotting disorders should discuss CoQ10 with their hematologist. And if you’re taking thyroid medication, be aware that some case reports suggest CoQ10 may affect thyroid hormone levels, though this hasn’t been studied systematically in pregnant women.
For women with uncomplicated pregnancies who are not taking prescription medications, the risk profile of CoQ10 at standard supplement doses appears low. The compound is naturally present in food (organ meats, fatty fish, whole grains, and some vegetables all contain small amounts), and your body produces it endogenously. A supplement at 100 to 200 mg per day adds to that baseline, and the clinical data available so far has not flagged problems at those levels. The gap in the evidence is about certainty, not about warning signs. The research we have points toward safety; what’s missing is the volume of data that would let organizations make confident public recommendations.